Published in J Allergy Clin Immunol on August 01, 2001
Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease. AAPS J (2009) 1.48
Human asthma phenotypes: from the clinic, to cytokines, and back again. Immunol Rev (2011) 1.29
Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract. J Allergy Clin Immunol (2010) 1.25
Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma. Clin Exp Immunol (2002) 1.07
Stratified approaches to the treatment of asthma. Br J Clin Pharmacol (2013) 0.98
Allergen-induced airway remodelling. Eur Respir J (2007) 0.98
Second-generation minimal physiologically-based pharmacokinetic model for monoclonal antibodies. J Pharmacokinet Pharmacodyn (2013) 0.98
CpG-containing immunostimulatory DNA sequences elicit TNF-alpha-dependent toxicity in rodents but not in humans. J Clin Invest (2009) 0.96
Recent advances in the pathological understanding of eosinophilic esophagitis. Expert Rev Gastroenterol Hepatol (2015) 0.92
Biologic therapies targeting eosinophils: current status and future prospects. J Allergy Clin Immunol Pract (2015) 0.90
Recent advances in the treatment of eosinophilic esophagitis. Expert Rev Clin Immunol (2010) 0.85
How safe are the biologicals in treating asthma and rhinitis? Allergy Asthma Clin Immunol (2009) 0.84
Application of quantitative pharmacology in development of therapeutic monoclonal antibodies. AAPS J (2010) 0.84
The eosinophil surface receptor epidermal growth factor-like module containing mucin-like hormone receptor 1 (EMR1): a novel therapeutic target for eosinophilic disorders. J Allergy Clin Immunol (2014) 0.84
The consequences of not having eosinophils. Allergy (2013) 0.83
Mepolizumab in eosinophilic disorders. Expert Rev Clin Immunol (2011) 0.83
Systemic administration of olygodeoxynucleotides with CpG motifs at priming phase reduces local Th2 response and late allergic rhinitis in BALB/c mice. Inflammation (2007) 0.82
Effect of formulation on the stability and aerosol performance of a nebulized antibody. MAbs (2014) 0.80
Potent neutralizing anti-CD1d antibody reduces lung cytokine release in primate asthma model. MAbs (2015) 0.78
VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations. MAbs (2014) 0.78
Update on reslizumab for eosinophilic asthma. Expert Opin Biol Ther (2015) 0.78
Immunotherapeutic approaches for the treatment of eosinophilic esophagitis. Immunotherapy (2014) 0.77
Subtypes of asthma defined by epithelial cell expression of messenger RNA and microRNA. Ann Am Thorac Soc (2013) 0.76
Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cells. Oncotarget (2014) 0.76
Pulmonary pharmacodynamics of an anti-GM-CSFRα antibody enables therapeutic dosing that limits exposure in the lung. MAbs (2016) 0.76
Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential. Ther Adv Chronic Dis (2016) 0.75
Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases. J Asthma Allergy (2015) 0.75
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state. Nat Commun (2017) 0.75
The effects of montelukast on tissue inflammatory and bone marrow responses in murine experimental allergic rhinitis: interaction with interleukin-5 deficiency. Immunology (2007) 0.75
Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer. Curr Allergy Asthma Rep (2012) 0.75
Reslizumab in the management of poorly controlled asthma: the data so far. J Asthma Allergy (2016) 0.75
Single nucleotide polymorphisms in the FcγR3A and TAP1 genes impact ADCC in cynomolgus monkey PBMCs. Immunogenetics (2017) 0.75
Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1991) 4.40
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem (1998) 3.88
Induction of Bradyrhizobium japonicum common nod genes by isoflavones isolated from Glycine max. Proc Natl Acad Sci U S A (1987) 3.41
Bone metastases in Wilms' tumour. Clin Radiol (1975) 2.52
A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells. J Virol (1995) 2.35
Drosophila genes Posterior Sex Combs and Suppressor two of zeste encode proteins with homology to the murine bmi-1 oncogene. Nature (1991) 2.33
Morphometric analysis of recombinant soluble CD4-mediated release of the envelope glycoprotein gp120 from HIV-1. AIDS Res Hum Retroviruses (1990) 2.13
The role of integration host factor in gene expression in Escherichia coli. Mol Microbiol (1992) 2.12
Inflammatory mediators of experimental colitis in rats. Gastroenterology (1989) 2.01
Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. Cancer Res (1981) 2.01
Expression of human tissue factor under the control of the mouse tissue factor promoter mediates normal hemostasis in knock-in mice. J Thromb Haemost (2007) 2.00
Equine hepatic insufficiency. Vet Clin North Am (1973) 1.92
Argon laser iridotomy in the treatment of patients with primary angle-closure or pupillary block glaucoma: a clinicopathologic study. Ophthalmology (1978) 1.82
Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120. J Virol (1993) 1.68
Inhibition of CD23 processing correlates with inhibition of IL-4-stimulated IgE production in human PBL and hu-PBL-reconstituted SCID mice. Clin Exp Allergy (2000) 1.66
The ilvB locus of Escherichia coli K-12 is an operon encoding both subunits of acetohydroxyacid synthase I. Nucleic Acids Res (1985) 1.49
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44
Intergeneric transfer of genes involved in the Rhizobium-legume symbiosis. Science (1977) 1.43
Single-organism model of host defense against infection: a novel immunotoxicologic approach to evaluate immunomodulatory drugs. Toxicol Pathol (1997) 1.40
Soluble CD4 and dextran sulfate mediate release of gp120 from HIV-1: implications for clinical trials. J Acquir Immune Defic Syndr (1991) 1.38
Multiple-site carcinogenicity of benzene in Fischer 344 rats and B6C3F1 mice. Environ Health Perspect (1989) 1.34
Acute respiratory bronchiolitis: an ultrastructural and autoradiographic study of epithelial cell injury and renewal in rhesus monkeys exposed to ozone. Am J Pathol (1980) 1.32
Strain-Specific Inhibition of nod Gene Induction in Bradyrhizobium japonicum by Flavonoid Compounds. Appl Environ Microbiol (1990) 1.25
Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virus. J Virol (1994) 1.24
Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells. Antimicrob Agents Chemother (1992) 1.24
Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction. Clin Cancer Res (2000) 1.24
Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4. J Immunol (2000) 1.23
Alveolar macrophages differ from blood monocytes in human IL-1 beta release. Quantitation by enzyme-linked immunoassay. J Immunol (1989) 1.23
Laser iridectomy. A controlled study comparing argon and neodymium: YAG. Ophthalmology (1986) 1.23
Short term morphologic effects of high ambient levels of ozone on lungs of rhesus monkeys. Lab Invest (1977) 1.22
Maximization of signal derived from cDNA microarrays. Biotechniques (2001) 1.20
Oxygen toxicity: augmentation of antioxidant defense mechanisms in rat lung. Am J Physiol (1976) 1.18
Integration host factor is a negative effector of in vivo and in vitro expression of ompC in Escherichia coli. J Bacteriol (1990) 1.16
Behavioral role of the sexcombs in Drosophila melanogaster and Drosophila simulans. Behav Genet (1977) 1.14
Chronic bronchiolitis in nonhuman primates after prolonged ozone exposure. Am J Pathol (1981) 1.14
Isolation of the left innominate artery, a right arch, and a left patent ductus arteriosus. AJR Am J Roentgenol (1979) 1.14
EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes. J Mol Cell Cardiol (2001) 1.14
Pulmonary responses of rats to ambient levels of ozone: effects of 7-day intermittent or continuous exposure. Lab Invest (1976) 1.13
The preparation and application of functionalised synthetic oligonucleotides: III. Use of H-phosphonate derivatives of protected amino-hexanol and mercapto-propanol or -hexanol. Nucleic Acids Res (1988) 1.11
Molecular genetics of the Posterior sex combs/Suppressor 2 of zeste region of Drosophila: aberrant expression of the Suppressor 2 of zeste gene results in abnormal bristle development. Genetics (1991) 1.11
Interaction of cyclic AMP receptor protein with the ilvB biosynthetic operon in E. coli. Nucleic Acids Res (1984) 1.10
The Klippel-Trenaunay syndrome: clinical and radiological aspects. Radiology (1978) 1.10
Pulmonary effects of prolonged ozone insult in rats. Morphometric evaluation of the central acinus. Lab Invest (1980) 1.10
Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthma. Br J Pharmacol (2012) 1.10
The effects of radiation on Chicago Metropolitan Sanitary District municipal and industrial wastewaters. J Water Pollut Control Fed (1969) 1.10
Analysis of the interaction between human interleukin-5 and the soluble domain of its receptor using a surface plasmon resonance biosensor. J Mol Recognit (1994) 1.08
Epidemiology of infection by nontuberculous mycobacteria. VII. Absence of mycobacteria in southeastern groundwaters. Am Rev Respir Dis (1987) 1.08
Assessment of avascular renal mass lesions: the use of nephrotomography, arteriography, cyst puncture, double contrast study and histochemical and histopathologic examination of the aspirate. South Med J (1972) 1.08
Precise measurement of the e+e- --> pi+pi-(gamma) cross section with the initial state radiation method at BABAR. Phys Rev Lett (2009) 1.07
Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma. Clin Exp Immunol (2002) 1.07
Characterization of CD4-gp120 activation intermediates during human immunodeficiency virus type 1 syncytium formation. AIDS Res Hum Retroviruses (1996) 1.07
Cloning, pharmacology, and tissue distribution of G-protein-coupled receptor GPR105 (KIAA0001) rodent orthologs. Genomics (2001) 1.06
Comparison of adipose tissue changes following administration of rosiglitazone in the dog and rat. Diabetes Obes Metab (2001) 1.06
Estrogen receptor negative and progesterone receptor positive primary breast cancer: pathological characteristics and clinical outcome. Institut Curie Breast Cancer Study Group. Breast Cancer Res Treat (1998) 1.05
Measurement of |V(cb)| and the form-factor slope in B --> Dl- nu(l) decays in events tagged by a fully reconstructed B meson. Phys Rev Lett (2010) 1.05
Supravalvar aortic stenosis. Br Heart J (1973) 1.04
Percutaneous drainage of pancreatic pseudocysts and abscesses. Radiology (1982) 1.04
Alveolar fluid neutrophil elastase activity in the adult respiratory distress syndrome is complexed to alpha-2-macroglobulin. J Clin Invest (1988) 1.03
Radiation exposure to the paediatric patient from cardiac catheterization and angiocardiography. Br J Radiol (1980) 1.03
Neodymium-YAG laser iridectomies in glaucoma associated with closed or occludable angles. Am J Ophthalmol (1986) 1.03
Percutaneous drainage in the management of hepatic abscesses. Surg Clin North Am (1981) 1.02
Phenotypic consequences and genetic interactions of a null mutation in the Drosophila Posterior Sex Combs gene. Dev Genet (1991) 1.02
Laser peripheral iridectomy comparing Q-switched neodymium YAG with argon. Trans Ophthalmol Soc U K (1985) 1.01
Strong association of simian immunodeficiency virus (SIVagm) envelope glycoprotein heterodimers: possible role in receptor-mediated activation. AIDS Res Hum Retroviruses (1992) 1.01
Percutaneous dilatation in primary sclerosing cholangitis: two experiences. AJR Am J Roentgenol (1981) 0.99
Temporal relation between neutrophil accumulation and myocardial reperfusion injury. Am J Physiol (1988) 0.99
Ultrastructural evidence of an interaction between Env and Gag proteins during assembly of HIV type 1. AIDS Res Hum Retroviruses (1995) 0.99
Spontaneous progressive multifocal leukoencephalopathy (PML) in macaques. Nature (1975) 0.99
Distribution and kinetics of PBB residues in cattle. Environ Health Perspect (1978) 0.98
ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. J Appl Physiol (1985) (1993) 0.98
Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virus. J Virol (1994) 0.98
A comparative study of cell renewal after exposure to ozone or oxygen. Response of terminal bronchiolar epithelium in the rat. Am Rev Respir Dis (1978) 0.98
Variation of techniques on the results of argon laser trabeculoplasty. Ophthalmology (1983) 0.97
Total occlusions of the femoropopliteal artery: high technical success rate of conventional balloon angioplasty. Radiology (1989) 0.97
Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock. Circ Res (1991) 0.97
The hematologic effects of cefonicid and cefazedone in the dog: a potential model of cephalosporin hematotoxicity in man. Toxicol Appl Pharmacol (1987) 0.97
Argon laser iridotomy in primary angle-closure or pupillary block glaucoma. Trans Ophthalmol Soc U K (1979) 0.95
Human immunodeficiency virus and hepatitis B virus seroprevalence in an urban trauma population. J Trauma (1995) 0.95
Spatial requirements between haptenic and carrier determinants for T-dependent antibody responses. J Exp Med (1978) 0.94
Evidence of foam cell and cholesterol crystal formation in macrophages incubated with oxidized LDL by fluorescence and electron microscopy. J Histochem Cytochem (1995) 0.94
Percutaneous Transluminal Angioplasty in Non-Atheroscklerotic Disease. Radiology (1980) 0.94
Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees. Clin Immunol (2001) 0.94
IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (Fc epsilonRII). Eur J Immunol (1997) 0.94
Utilization of volatile fatty acids in ruminants. IV. Relative activities of acetyl CoA synthetase and acetyl CoA hydrolase in mitochondria and intracellular localization of acetyl CoA synthetase. J Agric Food Chem (1972) 0.93
Glycoprotein secretion by tracheal explants cultured from rats exposed to ozone. Am Rev Respir Dis (1977) 0.93
A study of the effect of birth interval on the development of 9-year-old schoolchildren in Singapore. J Trop Pediatr Environ Child Health (1980) 0.93
Schistosoma mansoni phosphoenolpyruvate carboxykinase, a novel egg antigen: immunological properties of the recombinant protein and identification of a T-cell epitope. Infect Immun (2000) 0.93
A new universal linker for solid phase DNA synthesis. Nucleic Acids Res (1996) 0.93
Evaluating energy efficiency of site-specific tillage in maize in NE Italy. Bioresour Technol (2008) 0.93
Colchicine has opposite effects on interleukin-1 beta and tumor necrosis factor-alpha production. Am J Physiol (1991) 0.92
Utilization of volatile fatty acids in ruminants. I. Removal of them from portal blood by the liver. J Dairy Sci (1965) 0.92
An ontogenic study of the acute inflammatory response in the fetal rhesus monkey. II. The mediation of increased vascular permeability by histamine, compound 48/80 and bradykinin. Vet Pathol (1978) 0.91
Silicate pneumoconiosis and pulmonary fibrosis in horses from the Monterey-Carmel peninsula. Chest (1981) 0.91
Morphological methods for evaluation of pulmonary toxicity in animals. Annu Rev Pharmacol Toxicol (1976) 0.91
Alveolar macrophage migration. Influence of lung lining material and acute lung insult. Am Rev Respir Dis (1979) 0.90
Percutaneous abscess drainage. Surg Gynecol Obstet (1982) 0.90
Human whole blood interleukin-1-beta production: kinetics, cell source, and comparison with TNF-alpha. J Lab Clin Med (1992) 0.90
Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in monkeys. J Pharmacol Exp Ther (1999) 0.90